Traditionally, drugs were extracted from plants and microorganisms.
The heart drug digitalis originates from foxgloves
the painkiller aspirin originates from willow
penicillin was discovered by Alexander Fleming from the penicillium mould
Most new drugs are made by chemists in the pharmaceutical industry. However, the starting point may still be a chemical extracted from a plant
New medical drugs need to be tested and trialled to:
make sure they’re safe for people to use
make sure they’re effective
A drug’s toxicity is a measure of how harmful the drug is to the person taking it
A drug’s efficacy is a measure of how well the drug works
A drug’s dosage is how much of, and how often, the drug should be taken.
During preclinical testing of a new drug, cells, tissues and live animals are used to test the drug’s toxicity, efficacy and dosage.
During clinical trials of a new drug, healthy volunteers and patients test the drug.
Trials start with a very low dose - if the drug’s safe, more trials find the optimum dosage.
double blind trials then test the drug’s efficacy against a placebo
A new drug is tested against a placebo to check that the drug actually works and it’s not the placebo effect
In a double blind trial of a new drug, the testers are randomly split into two groups - one group gets a placebo and the other gets the new drug. Nobody knows who got what, not even the scientists running the trial, until the trial ends
Benefits of a double blind trial of a new drug
It minimises the placebo effect
it reduces the chance of a scientist influencing the results - either subconsciously or on purpose
The results of a new drug’s test and trials are only published after peer review to prevent false claims about the drug being made